Market Overview:
The global ondansetron hydrochloride market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of gastrointestinal disorders, rising demand for ondansetron hydrochloride in emerging markets, and growing awareness about the benefits of ondansetron hydrochloride. Based on type, the global ondansetron hydrochloride market can be segmented into purity greater than or equal to 97%, purity greater than or equal to 98%, and purity greater than or equal to 99%. The purity greater than or equal to 97% segment is expected to account for the largest share of the global ondansetron hydrochloride market in 2018. This segment is also projected to grow at a CAGR of 6.8% during the forecast period from 2018to 2030. The injection segment is expected t o account for t he largest share o f th e globa l o nda ns et ron h ydrochl ori de ma rket i n 2 018 .Thi s segm ent i s al so projected t o gr ow at a CA GR o f 6 .
Product Definition:
Ondansetron Hydrochloride is an antiemetic drug used to prevent nausea and vomiting. It is especially effective against vomiting caused by chemotherapy.
PurityGreater than or equal to97%:
The global Ondansetron Hydrochloride market is anticipated to grow at a lucrative rate during the forecast period. The growth of this market is attributed to rising incidences of oncological diseases and increasing awareness regarding its benefits in chemotherapy. Moreover, growing demand for high potency anti-nausea drug and increasing prevalence of cancer are also expected to drive the growth factor for this market during the forecast period.
PurityGreater than or equal to98%:
Ondansetron Hydrochloride is a pure and strong anti-nausea drug, which works by blocking the action of serotonin in the brain. It is used to treat nausea and vomiting caused due to radiation therapy, chemotherapy treatment for cancer or severe allergic reactions. Ondansetron hydrochloride also has uses in treating conditions such as acute pancreatitis, severe acute gastritis and peptic ulcer disease.
Application Insights:
Ondansetron hydrochloride injection was the most prominent application segment and accounted for a revenue share of 91.1% in 2017. The product is used for the treatment of nausea, vomiting and abdominal pain caused by various diseases such as cancer, AIDS, cholera and Crohn¢â‚¬â„¢s disease among others. In addition to this, it is also used for prevention of nausea during surgery or radiotherapy among other applications.
The oral capsule form of ondansetron hydrochloride is expected to be the fastest-growing segment at an estimated CAGR 5.0% from 2018 to 2030 owing to its growing usage as an antiemetic agent in chemotherapy across various tumor types including pancreatic cancer.
Regional Analysis:
North America dominated the global market in 2017. The presence of key manufacturers and suppliers coupled with high demand for anti-nausea medication is anticipated to be the major factor responsible for its largest share. In addition, increasing R&D activities by various companies to develop novel formulations that are safer and more effective is expected to fuel growth over the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising healthcare expenditure, growing population, improving economic conditions & increased awareness about Ondansetron Hydrochloride treatment options among patients.
Growth Factors:
- Increasing incidence of nausea and vomiting: The global incidence of nausea and vomiting is increasing due to various factors such as changing lifestyle, food habits, and environmental pollution. This is propelling the demand for ondansetron hydrochloride products.
- Rising awareness about the benefits of ondansetron hydrochloride: There is a growing awareness among people about the benefits of using ondansetron hydrochloride products for treating various types of nausea and vomiting conditions. This is fueling the growth of the market.
- Growing number of product approvals: The number of product approvals for ondansetron hydrochloride products is increasing globally, which is boosting their demand in both developed and developing countries alike. This will help fuel market growth in coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ondansetron Hydrochloride Market Research Report
By Type
PurityGreater than or equal to97%, PurityGreater than or equal to98%, PurityGreater than or equal to99%
By Application
Ondansetron Hydrochloride Injection, Ondansetron Hydrochloride Oral Capsule
By Companies
Inke APIs, Beaukev, Cadila Pharmaceutical, Cambrex, Dr. Reddy’s, Tapi Teva, SMS Pharmaceuticals, Smaart Pharmaceutical, Changzhou Kangyun Jingxi Chemical, Sinopharm Chuankang Pharmaceutical, Qilu Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Ondansetron Hydrochloride Market Report Segments:
The global Ondansetron Hydrochloride market is segmented on the basis of:
Types
PurityGreater than or equal to97%, PurityGreater than or equal to98%, PurityGreater than or equal to99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Ondansetron Hydrochloride Injection, Ondansetron Hydrochloride Oral Capsule
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Inke APIs
- Beaukev
- Cadila Pharmaceutical
- Cambrex
- Dr. Reddy’s
- Tapi Teva
- SMS Pharmaceuticals
- Smaart Pharmaceutical
- Changzhou Kangyun Jingxi Chemical
- Sinopharm Chuankang Pharmaceutical
- Qilu Pharmaceutical
Highlights of The Ondansetron Hydrochloride Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- PurityGreater than or equal to97%
- PurityGreater than or equal to98%
- PurityGreater than or equal to99%
- By Application:
- Ondansetron Hydrochloride Injection
- Ondansetron Hydrochloride Oral Capsule
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ondansetron Hydrochloride Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ondansetron hydrochloride is a medication used to treat nausea and vomiting. It is also used to prevent motion sickness.
Some of the key players operating in the ondansetron hydrochloride market are Inke APIs, Beaukev, Cadila Pharmaceutical, Cambrex, Dr. Reddy¢â‚¬â„¢s, Tapi Teva, SMS Pharmaceuticals, Smaart Pharmaceutical, Changzhou Kangyun Jingxi Chemical, Sinopharm Chuankang Pharmaceutical, Qilu Pharmaceutical.
The ondansetron hydrochloride market is expected to register a CAGR of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Ondansetron Hydrochloride Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Ondansetron Hydrochloride Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Ondansetron Hydrochloride Market - Supply Chain
4.5. Global Ondansetron Hydrochloride Market Forecast
4.5.1. Ondansetron Hydrochloride Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Ondansetron Hydrochloride Market Size (000 Units) and Y-o-Y Growth
4.5.3. Ondansetron Hydrochloride Market Absolute $ Opportunity
5. Global Ondansetron Hydrochloride Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Ondansetron Hydrochloride Market Size and Volume Forecast by Type
5.3.1. PurityGreater than or equal to97%
5.3.2. PurityGreater than or equal to98%
5.3.3. PurityGreater than or equal to99%
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Ondansetron Hydrochloride Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Ondansetron Hydrochloride Market Size and Volume Forecast by Application
6.3.1. Ondansetron Hydrochloride Injection
6.3.2. Ondansetron Hydrochloride Oral Capsule
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Ondansetron Hydrochloride Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Ondansetron Hydrochloride Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Ondansetron Hydrochloride Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Ondansetron Hydrochloride Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Ondansetron Hydrochloride Demand Share Forecast, 2019-2026
9. North America Ondansetron Hydrochloride Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Ondansetron Hydrochloride Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Ondansetron Hydrochloride Market Size and Volume Forecast by Application
9.4.1. Ondansetron Hydrochloride Injection
9.4.2. Ondansetron Hydrochloride Oral Capsule
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Ondansetron Hydrochloride Market Size and Volume Forecast by Type
9.7.1. PurityGreater than or equal to97%
9.7.2. PurityGreater than or equal to98%
9.7.3. PurityGreater than or equal to99%
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Ondansetron Hydrochloride Demand Share Forecast, 2019-2026
10. Latin America Ondansetron Hydrochloride Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Ondansetron Hydrochloride Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Ondansetron Hydrochloride Market Size and Volume Forecast by Application
10.4.1. Ondansetron Hydrochloride Injection
10.4.2. Ondansetron Hydrochloride Oral Capsule
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Ondansetron Hydrochloride Market Size and Volume Forecast by Type
10.7.1. PurityGreater than or equal to97%
10.7.2. PurityGreater than or equal to98%
10.7.3. PurityGreater than or equal to99%
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Ondansetron Hydrochloride Demand Share Forecast, 2019-2026
11. Europe Ondansetron Hydrochloride Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Ondansetron Hydrochloride Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Ondansetron Hydrochloride Market Size and Volume Forecast by Application
11.4.1. Ondansetron Hydrochloride Injection
11.4.2. Ondansetron Hydrochloride Oral Capsule
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Ondansetron Hydrochloride Market Size and Volume Forecast by Type
11.7.1. PurityGreater than or equal to97%
11.7.2. PurityGreater than or equal to98%
11.7.3. PurityGreater than or equal to99%
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Ondansetron Hydrochloride Demand Share, 2019-2026
12. Asia Pacific Ondansetron Hydrochloride Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Ondansetron Hydrochloride Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Ondansetron Hydrochloride Market Size and Volume Forecast by Application
12.4.1. Ondansetron Hydrochloride Injection
12.4.2. Ondansetron Hydrochloride Oral Capsule
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Ondansetron Hydrochloride Market Size and Volume Forecast by Type
12.7.1. PurityGreater than or equal to97%
12.7.2. PurityGreater than or equal to98%
12.7.3. PurityGreater than or equal to99%
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Ondansetron Hydrochloride Demand Share, 2019-2026
13. Middle East & Africa Ondansetron Hydrochloride Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Ondansetron Hydrochloride Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Ondansetron Hydrochloride Market Size and Volume Forecast by Application
13.4.1. Ondansetron Hydrochloride Injection
13.4.2. Ondansetron Hydrochloride Oral Capsule
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Ondansetron Hydrochloride Market Size and Volume Forecast by Type
13.7.1. PurityGreater than or equal to97%
13.7.2. PurityGreater than or equal to98%
13.7.3. PurityGreater than or equal to99%
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Ondansetron Hydrochloride Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Ondansetron Hydrochloride Market: Market Share Analysis
14.2. Ondansetron Hydrochloride Distributors and Customers
14.3. Ondansetron Hydrochloride Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Inke APIs
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Beaukev
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Cadila Pharmaceutical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cambrex
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Dr. Reddys
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Tapi Teva
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. SMS Pharmaceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Smaart Pharmaceutical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Changzhou Kangyun Jingxi Chemical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sinopharm Chuankang Pharmaceutical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Qilu Pharmaceutical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
